Baltimore Sun Sunday

MEDICINE&SCIENCE

-

More than 114,000 people are waiting for organs in the U.S. and fewer than 35,000 organs were transplant­ed last year, according to the United Network for Organ Sharing, or UNOS. Transplant centers want to make sure donated organs aren’t wasted.

“If you’re receiving a lifesaving organ, you have to be able to afford it,” said Kelly Green, executive director of HelpHopeLi­ve, the Pennsylvan­ia organizati­on that has helped Mannion.

His friends and family have rallied, flocking to fundraiser­s that ranged from hair salon cut-a-thons to golf tournament­s, raising nearly $115,000 so far for transplant-related care.

Allowing financial factors to determine who gets a spot on the waiting list strikes many as unfair, Caplan said.

“It may be a source of anger, because when we’re looking for organs, we don’t like to think that they go to the rich,” he said.

“In reality, it’s largely true.”

Nearly half of the patients waiting for organs in the U.S. have private health insurance, UNOS data show. The rest are largely covered by the government, including Medicaid, the federal program for the disabled and poor, and Medicare.

Medicare also covers kidney transplant­s for all patients with end-stage renal disease. But, there’s a catch.

While the cost of a kidney transplant is covered for people younger than 65, the program halts payment for anti-rejection drugs after 36 months. That leaves many patients facing sudden bills, said Tonya Saffer, vice president of health policy for the National Kidney Foundation.

Legislatio­n that would extend Medicare coverage for those drugs has been stalled for years.

For Alex Reed, 28, of Pittsburgh, who received a kidney transplant three years ago, coverage for the dozen medication­s he takes ended Nov. 30. His mother, Bobbie Reed, 62, has been scrambling for a solution.

“We can’t pick up those costs,” said Reed, whose family runs an independen­t insurance firm. “It would be at least $3,000 or $4,000 a month.”

Prices for the drugs, which include powerful medication­s that prevent the body from rejecting the organs, have been falling in recent years as more generic versions have come to market, Saffer said.

But “the cost can still be hard on the budget,” she added.

It’s been a struggle for decades to get transplant­s and associated expenses covered by insurance, said Dr. Maryl Johnson, a heart failure and transplant cardiologi­st at the University of Wisconsin School of Medicine and Public Health.

“It’s unusual that there’s 100 percent coverage for everything,” said Johnson, a leader in the field for 30 years.

GoFundMe efforts have become a popular way for sick people to raise money. But when patients need to raise money, they should use fundraisin­g organizati­ons specifical­ly aimed at those costs, transplant experts say, including HelpHopeLi­ve, the National Foundation for Transplant­s and the American Transplant Foundation.

There’s no guarantee funds generated through such general sites such as GoFundMe will be used for the intended purpose.

In addition, the money likely will be regarded as taxable income that could jeopardize other resources, said Michelle Gilchrist, president and chief executive for the National Foundation for Transplant­s.

Newspapers in English

Newspapers from United States